Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice

Biochemical and Biophysical Research Communications

Volumn 378, Issue 2, 2009, Pages 192-196

  Lee, Hyeon ^a   Kim, Soo In ^a   Shin, Duckhyang ^a   Yoon, Yeup ^a   Choi, Tae Hyun ^b   Cheon, Gi Jeong ^b   Kim, Meehyein ^a  

^a Mogam Biotechnology Research Institute   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Hepatitis C virus; Liver specific delivery; Recombinant apolipoprotein A I; RNA interference; Small interfering RNA

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER; LIPOSOME; PLASMA DERIVED APOLIPOPROTEIN A1; RECOMBINANT APOLIPOPROTEIN A1; SCAVENGER RECEPTOR BI; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL TRANSPORT; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; GENE TARGETING; HEPATITIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TISSUE SPECIFICITY; VIRUS INHIBITION;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIPOSOMES; LIVER; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; TISSUE DISTRIBUTION;

ESCHERICHIA COLI; HEPATITIS C VIRUS; MUS;

EID: 57049173352     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.029     Document Type: Article

References (27)

1. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., and Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65 (1991) 1105-1113
2. Grakoui A., Wychowski C., Lin C., Feinstone S.M., and Rice C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67 (1993) 1385-1395
3. Shimotohno K., Tanji Y., Hirowatari Y., Komoda Y., Kato N., and Hijikata M. Processing of the hepatitis C virus precursor protein. J. Hepatol. 22 (1995) 87-92
4. Anonymous. Hepatitis C--global prevalence (update). Wkly Epidemiol. Rec. 75 (2000) 18-19
5. Theodore D., and Fried M.W. Natural history and disease manifestations of hepatitis C infection. Curr. Top. Microbiol. Immunol. 242 (2000) 43-54
6. Behrens S.E., Tomei L., and De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 15 (1996) 12-22
7. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., and Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
8. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
9. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
10. Nykanen A., Haley B., and Zamore P.D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107 (2001) 309-321
11. Kapadia S.B., Brideau-Andersen A., and Chisari F.V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA 100 (2003) 2014-2018
12. Kim M., Shin D., Kim S.I., and Park M. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Virus Res. 122 (2006) 1-10
13. Kim S.I., Shin D., Choi T.H., Lee J.C., Cheon G.J., Kim K.Y., Park M., and Kim M. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. Mol. Ther. 15 (2007) 1145-1152
14. Nishina K., Unno T., Uno Y., Kubodera T., Kanouchi T., Mizusawa H., and Yokota T. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol. Ther. 16 (2008) 734-740
15. Rozema D.B., Lewis D.L., Wakefield D.H., Wong S.C., Klein J.J., Roesch P.L., Bertin S.L., Reppen T.W., Chu Q., Blokhin A.V., Hagstrom J.E., and Wolff J.A. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. USA 104 (2007) 12982-12987
16. Sato Y., Murase K., Kato J., Kobune M., Sato T., Kawano Y., Takimoto R., Takada K., Miyanishi K., Matsunaga T., Takayama T., and Niitsu Y. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 26 (2008) 431-442
17. Gordon J.I., Sims H.F., Lentz S.R., Edelstein C., Scanu A.M., and Strauss A.W. Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease. J. Biol. Chem. 258 (1983) 4037-4044
18. Saku K., von Eckardstein A., Zhang B., Liu R., Jimi S., Ou J., Ohta T., Assmann G., and Arakawa K. In vivo kinetics of human apolipoprotein A-I variants in rabbits. Eur. J. Clin. Invest. 29 (1999) 196-203
19. Xu S., Laccotripe M., Huang X., Rigotti A., Zannis V.I., and Krieger M. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38 (1997) 1289-1298
20. Shin D., Kim S.I., Park M., and Kim M. Immunostimulatory properties and antiviral activity of modified HBV-specific siRNAs. Biochem. Biophys. Res. Commun. 364 (2007) 436-442
21. Panagotopulos S.E., Witting S.R., Horace E.M., Nicholas Maiorano J., and Sean Davidson W. Bacterial expression and characterization of mature apolipoprotein A-I. Protein Expr. Purif. 25 (2002) 353-361
22. Shin D., Kim S.I., Kim M., and Park M. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice. Virus Res. 119 (2006) 146-153
23. Dang Q., Walker D., Taylor S., Allan C., Chin P., Fan J., and Taylor J. Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus. J. Biol. Chem. 270 (1995) 22577-22585
24. Le M., Okuyama T., Cai S.R., Kennedy S.C., Bowling W.M., Flye M.W., and Ponder K.P. Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy. Blood 89 (1997) 1254-1259
25. Lerch P.G., Fortsch V., Hodler G., and Bolli R. Production and characterization of a reconstituted high density lipoprotein for therapeutic applications. Vox Sang. 71 (1996) 155-164
26. Templeton N.S., Lasic D.D., Frederik P.M., Strey H.H., Roberts D.D., and Pavlakis G.N. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol. 15 (1997) 647-652
27. Hunter R. Standardization of the chloramine-T method of protein iodination. Proc. Soc. Exp. Biol. Med. 133 (1970) 989-992